CTRI/2024/08/072195尚未招募4 期
Comparative evaluation of Palmitoylethanolamide (PEA) vs Ketorolac in Pain management after Third Molar Surgery A Randomised Controlled Study - NI
Hemang Kapoor0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 4 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Patients aged between 18 to 40 under going 3rd molar extraction.
- •No systemic disease. Healthy human volunteer. Does not smoke or consume any substance that interferes with study.
排除标准
- •Patients with known allergies to Palmitoylethanolamide or Ketorolac.
- •History of gastrointestinal ulcers, renal or hepatic impairment.
- •Pregnant woman and lactating mother.
研究者
相似试验
已完成
3 期
comparison of two drugs for checking effectiveness for nerve related paiCTRI/2021/08/036091Dr Amlendu shekhar60
已完成
3 期
Effect of Palmitoylethanolamide (PEA) compared to a placebo on symptoms for upperrespiratory tract infection (URTI) in an Adult Population – A double blind, randomised controlledtrial.ACTRN12620000846921RDC Global Pty Ltd428
尚未招募
2 期
Research on Palmitoylethanolamide (PEA) Extract in Healthy PeopleCTRI/2024/02/062402Tilman SA
招募中
3 期
Effect of Palmitoylethanolamide (PEA) and Oleoylethanolamide (OEA) Compared to a Placebo on the Gut Microbiome in an Adult Population – A double blind, randomised controlled trial.Gut microbiomeGut barrier functionGut biochemistryOral and Gastrointestinal - Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colonAlternative and Complementary Medicine - Other alternative and complementary medicineMetabolic and Endocrine - Normal metabolism and endocrine development and functionACTRN12621000017820RDC Global Pty Ltd120
已完成
3 期
The effect of Palmitoylethanolamide (PEA) supplementation on the symptoms of allergic rhinitis - A double-blind placebo controlled trial.Allergic rhinitisInflammatory and Immune System - AllergiesACTRN12619001368123RDC Global Pty Ltd162